Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model (Q39244509)
scientific article
Language:
Current Data About Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model
(P31) (Q13442814)
(P248)
(P698) 34804
(P813) Sunday, September 10, 2017

(P304) 74-86
(P248)
(P698) 34804
(P813) Sunday, September 10, 2017

(P407) (Q1860)

(P433) 2
(P248)
(P698) 34804
(P813) Sunday, September 10, 2017

(P478) 5
(P248)
(P698) 34804
(P813) Sunday, September 10, 2017

(P577) Monday, January 1, 1979
(P248)
(P698) 34804
(P813) Sunday, September 10, 2017

(P921) (Q41112)

(P1433) (Q7002585)
(P248)
(P698) 34804
(P813) Sunday, September 10, 2017

(P1476) "Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model" (language: en)
(P248)
(P698) 34804
(P813) Sunday, September 10, 2017

(P2093) Singh MM
(P1545) 1
(P248)
(P698) 34804
(P813) Sunday, September 10, 2017

Kay SR
(P1545) 2
(P248)
(P698) 34804
(P813) Sunday, September 10, 2017

other details
description scientific article

External Links
(P356) 10.1159/000117667
(P698) 34804